Aditxt(us:ADTX)
4.52
+0.67%
Updated on 2025-04-02
Open:4.18
Close:4.52
High:4.91
Low:4.17
Prev Close:4.49
Volume:160331.00
Turnover:722889.44
Turnover Ratio:13.83%
Shares:1.16M
MarketCap:5.24M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 11 | 16963 | 0.85% | 1 | 2 | 5 |
| 2024-03-31 | 13 | 17804 | 1.07% | 3 | 2 | 5 |
| 2023-12-31 | 12 | 4711 | 0.36% | 1 | 1 | 5 |
| 2023-09-30 | 17 | 67174 | 18.26% | 5 | 3 | 6 |
| 2023-06-30 | 16 | 17476 | 0.26% | 2 | 2 | 4 |
| 2023-03-31 | 16 | 679194 | 14.05% | 2 | 2 | 2 |
| 2022-12-31 | 16 | 685090 | 15.91% | 2 | 4 | 6 |
| 2022-09-30 | 29 | 289608 | 7.76% | 3 | 7 | 16 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Geode Capital Management, Llc | 14487 | 0.87% | 14487 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 2217 | 0.13% | 1240 | 126.92% |
| 2024-03-31 | Group One Trading, L.P. | 603 | 0.04% | 603 | |
| 2024-03-31 | Natixis | 250 | 0.01% | 0 | |
| 2024-03-31 | Ubs Group Ag | 185 | 0.01% | -1746 | -90.42% |
| 2024-03-31 | Morgan Stanley | 37 | 0.00% | 0 | |
| 2024-03-31 | Wells Fargo & Company/Mn | 13 | 0.00% | 12 | 1200.00% |
| 2024-03-31 | Osaic Holdings, Inc. | 11 | 0.00% | 0 | |
| 2024-03-31 | Fmr Llc | 1 | 0.00% | 1 | |
| 2024-03-31 | Game Plan Financial Advisors, Llc | 0 | -1 |
About
ADiTx Therapeutics, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Loma Linda, CA.
Address:2569 Wyandotte Street,Suite 101
Website:http://www.aditxt.com
Market Movers